Total Valuation
KOREA UNITED PHARM, INC. has a market cap or net worth of ₩262.76B. The enterprise value is ₩113.07K.
Market Cap₩262.76B
Enterprise Value₩113.07K
Share Statistics
KOREA UNITED PHARM, INC. has 15,910,775 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding15,910,775
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
KOREA UNITED PHARM, INC.’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 7.94%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)7.94%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee308.51M
Profits Per Employee40.93M
Employee Count936
Asset Turnover0.56
Inventory Turnover1.76
Valuation Ratios
The current PE Ratio of KOREA UNITED PHARM, INC. is 3.7. KOREA UNITED PHARM, INC.’s PEG ratio is 0.39.
PE Ratio3.7
PS Ratio1.08
PB Ratio0.69
Price to Fair Value0.69
Price to FCF11.25
Price to Operating Cash Flow3.41
PEG Ratio0.39
Income Statement
In the last 12 months, KOREA UNITED PHARM, INC. had revenue of 288.76B and earned 38.31B in profits. Earnings per share was 2.61K.
Revenue288.76B
Gross Profit175.41B
Operating Income48.91B
Pretax Income49.82B
Net Income38.31B
EBITDA60.47B
Earnings Per Share (EPS)2.61K
Cash Flow
In the last 12 months, operating cash flow was 83.93B and capital expenditures -42.60B, giving a free cash flow of 41.32B billion.
Operating Cash Flow83.93B
Free Cash Flow41.32B
Free Cash Flow per Share2.60K
Dividends & Yields
KOREA UNITED PHARM, INC. pays an annual dividend of ₩610, resulting in a dividend yield of 3.35%
Dividend Per Share₩610
Dividend Yield3.35%
Payout Ratio12.39%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.06
52-Week Price Change-8.04%
50-Day Moving Average17.85K
200-Day Moving Average18.94K
Relative Strength Index (RSI)47.08
Average Volume (3m)25.34K
Important Dates
KOREA UNITED PHARM, INC. upcoming earnings date is Nov 18, 2026, TBA (Confirmed).
Last Earnings DateAug 14, 2026
Next Earnings DateNov 18, 2026
Ex-Dividend Date―
Financial Position
KOREA UNITED PHARM, INC. as a current ratio of 5.63, with Debt / Equity ratio of 2.99%
Current Ratio5.63
Quick Ratio4.28
Debt to Market Cap0.04
Net Debt to EBITDA-0.43
Interest Coverage Ratio281.78
Taxes
In the past 12 months, KOREA UNITED PHARM, INC. has paid 11.50B in taxes.
Income Tax11.50B
Effective Tax Rate0.23
Enterprise Valuation
KOREA UNITED PHARM, INC. EV to EBITDA ratio is 4.72, with an EV/FCF ratio of 10.30.
EV to Sales0.99
EV to EBITDA4.72
EV to Free Cash Flow10.30
EV to Operating Cash Flow5.58
Balance Sheet
KOREA UNITED PHARM, INC. has ₩178.56B in cash and marketable securities with ₩14.86B in debt, giving a net cash position of ₩163.70B billion.
Cash & Marketable Securities₩178.56B
Total Debt₩14.86B
Net Cash₩163.70B
Net Cash Per Share₩10.29K
Tangible Book Value Per Share₩27.19K
Margins
Gross margin is 59.02%, with operating margin of 16.94%, and net profit margin of 13.27%.
Gross Margin59.02%
Operating Margin16.94%
Pretax Margin17.25%
Net Profit Margin13.27%
EBITDA Margin20.94%
EBIT Margin16.94%
Analyst Forecast
The average price target for KOREA UNITED PHARM, INC. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast4.13%
EPS Growth Forecast116.32%